Requests similar to 'COVID-19 Early Treatment Options - where are they?'
Decision not to provide information to Today FM or Mediaworks
Response by Pharmaceutical Management Agency to New Zealand Council for Civil Liberties on .
Refused.
Tēnā koe
Further to our previous communications, we have now published
[1]information about our communications approach for the Trikafta
consul...
Cost of PreP since funding began in 2018
Response by Pharmaceutical Management Agency to Elliot Ikilei on .
Successful.
Kia ora Elliot
Please find attached a response to your request for information received
by PHARMAC on 6 January 2021.
Please feel free to...
Estimating the number of people prescribed PrEP
Response by Pharmaceutical Management Agency to Bianca Sepulveda on .
Successful.
Kia ora Bianca
Please find attached a response to your recent request for information.
Ngā mihi
Melody Willis ([1]she/her) | Gove...
Molnupiravir for Horses, Zebras & Donkeys - offspring born with no teeth & skull missing
Response by Pharmaceutical Management Agency to Micky Turner on .
Successful.
Kia ora Micky
Please find a response for your request for information attached with this email.
Ngā mihi
Simon
Simon Mitchell | Senior Policy Adviso...
Trikafta Funding Announcement
Response by Pharmaceutical Management Agency to Phillip Hart on .
Partially successful.
Tçnâ koe Phillip
Further to our previous communications, we have now published
[1]information about our communications approach for the Trikafta...
Kia ora Felix
I am writing about your request for information under the Official
Information Act 1982 (OIA).
I confirm that we have receiv...
Correspondence between Pharmac and Draper Cormack re 2022-23-125; A1665003
Response by Pharmaceutical Management Agency to Harris Leigh on .
Successful.
Tēnā koe Harris
Please find a response to your request for information attached with this
email.
Ngā mihi, nā
Melody Willis ([1]...
Pfizer Contractual Agreement
Response by Pharmaceutical Management Agency to Chuck Schooner (Account suspended) on .
Long overdue.
Tēnā koe Chuck
Thank you for your email about the Pfizer contractual agreement.
May I please confirm whether your request relates to the agreement fo...
Information regarding Dexcom CGMS and Libre FGMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Mōrena D Smith
Thank you for your email and for your patience as we continue to collate and prepare documents in scope of your request.
We expect to...
Correspondence between Pharmac and NZMS
Response by Pharmaceutical Management Agency to D Smith on .
Awaiting classification.
Kia ora D Smith
Thank you for your email.
Your request has been received and logged. Our reference number for your
request is: 2021-22-016...
Process and progress of approval for pediatric/under 5’s covid vaccines
Response by Pharmaceutical Management Agency to Scout Barbour-Evans on .
Partially successful.
Tēnā koe Scout
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Servi...
Why have you restricted Ivermectin?
Response by Pharmaceutical Management Agency to Annie Weston on .
Successful.
Mōrena Annie
Please find a response to your request about ivermectin attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Servic...
OIA publication
Response by Pharmaceutical Management Agency to Rex Davey on .
Awaiting classification.
Kia ora Rex,
Please find a response to your OIA request attached.
Ngā mihi
Pharmac Government Services Team
22 November 2023
Rex Davey
Via email:...
Cost of funding Tramadol in 2019
Response by Pharmaceutical Management Agency to Brianna Stewart on .
Successful.
Kia ora Brianna
Please find the response to your OIA 2020-21-020 dated 18 August 2020
regarding tramadol funding for calendar year 2019.
N...
PTAC subcommittees- OIA request
Response by Pharmaceutical Management Agency to john luke on .
Successful.
Kia ora John
Please find attached to this email a response to your OIA request
2020-21-015 dated 14 July 2020.
Ngā mihi
Melody W...
Assessment bias toward new medicines - Ivermectin and Pfizer antiviral PF-07321332
Response by Ministry of Health to Adam Irish on .
Partially successful.
Kia ora Adam
Your request has been transferred from the Ministry of Health to Pharmac
for response. Our reference number for your request is 202...
Rolling reviews of safety & efficacy of (non-mRNA gene therapy) COVID-19 treatments
Response by Pharmaceutical Management Agency to J Bruning on .
Successful.
Kia ora
Please find a response to your request for information attached with this email.
Ngā mihi
Melody Willis (she/her) | Government Services Adv...
Procurement process for Cormack Draper
Response by Pharmaceutical Management Agency to Harris Leigh on .
Partially successful.
Tçnâ koe Harris
Please find a response to your below request for information attached to
this email.
Ngâ mihi, nâ
Melody Willis...
Discontinuation of Phenelzine Sulphare
Response by Pharmaceutical Management Agency to Megs on .
Successful.
Dear Megs,
Thank you for your request for official information, received by PHARMAC
on 23 April 2020.
Your request has been received and l...
Tçnâ koe
Please find a response to your request for information attached.
Ngâ mihi, nâ
Melody Willis (she/her) | Government Services Advisor
______...
COVID-19 Early Treatment Options
Request sent to Ministry of Health by Micky Turner on .
Successful.
Can you please advise if you are offering people with Covid-19 any of the following:
Fluvoxamine 89%
Budesonide 81%
Vitamin D 81%
Vitamin A 7...
Maori Advisory Committee
Response by Pharmaceutical Management Agency to Alan Riley on .
Successful.
Kia ora Alan,
Please find attached a response to your Official Information Act request,
which was received on 13 November 2024.
Please con...
COVID-19 Early Treatment Options - where are they?
Request sent to Andrew Little by Micky Turner on .
Long overdue.
Can you please advise if you have organized the supply of and are offering people with Covid-19 any of the following:
Fluvoxamine 89%
Budesonid...
All emails from the Chief Executive, Director of Operations and communications staff in 2022 mentioning continuous glucose monitors
Response by Pharmaceutical Management Agency to Stefan Clausing on .
Awaiting classification.
Kia ora Stefan,
Please find a response to your request attached to this email.
Kind regards,
Gendi McFadyen| Government Services Advisor
Te Pātaka W...
Kia ora T Murray
Thank you for your request for information, received by Pharmac on 21 December 2023. Your request has been received and logged. Our r...
